5
Total investments
2
Early stage
0
Mid stage
2
Late stage
9y
Years active
Portfolio
4 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Observer
Apr 2025
Gilgamesh is a clinical-stage biotech whose vision is to reshape how mental illnesses are treated by shifting away from symptom management to a focus on rapid-acting and durable therapies targeting the fundamental drivers of disease. We do this by designing best-in-class new chemical entities (NCEs) acting through proven mechanisms, which are optimized for safety, efficacy, and patient access
Investing Member
Aug 2019
Portfolia is the most powerful community of women and men investing in the companies we want in the world.
Our collective investments are changing health, active aging & longevity, sustainability, education, and the overall venture capital landscape while also backing diversity.
Our currently open funds are Femtech III, focused on enhancing the wellness of all women, and advancing innovation in womens health; and Active Aging & Longevity II, focused on significant opportunities and challenges in aging well, as well as those focused on new strides and technologies in the field of longevity.
We drive change while creating wealth.
If youd like to join us, email investorrelations@portfolia.com, and our Investor Relations Team will contact you.
Investor
Aug 2017
Faster. Easier. Safer. That's how we deliver next-gen mobile wallet, loyalty, and eCommerce solutions.
Our platform enables app-less commerce and we specialize in data acquisition and commerce through contactless payments, contactless tickets, and NFC-based solutions... all critical aspects of your COVID-19 response plan.
Experience · 6 entries
All (6)
Investments (5)
Board (3)
2025
Board Observer
Apr 2025
Gilgamesh is a clinical-stage biotech whose vision is to reshape how mental illnesses are treated by shifting away from symptom management to a focus on rapid-acting and durable therapies targeting the fundamental drivers of disease. We do this by designing best-in-class new chemical entities (NCEs) acting through proven mechanisms, which are optimized for safety, efficacy, and patient access
2023
Principal
Sep 2023
The future of mental wellness is being built today. Through its diversified investment fund, Palo Santo is positioned to increase the supply of clinically effective, affordable, and accessible mental health and addiction treatment solutions needed in today’s world.
Supported by a rapidly growing body of evidence and strong FDA support, psychedelic-assisted treatments represent a paradigm shift in mental health care. Yet the emerging ecosystem of business opportunities is highly fragmented and, with a lack of institutional capital available, Palo Santo is targeting high growth opportunities within biotech & drug development, health care services, and digital health solutions led by passionate, experienced, and ethical management teams. These businesses are positioned to have a profound impact on treating conditions such as depression, PTSD, anxiety, OCD, drug and alcohol dependence, chronic pain, Alzheimer’s, and a range of inflammatory-related illnesses.
2022
Board Member
Nov 2022
Pickering Laboratories, Inc. is a chemistry company most commonly known for HPLC Post-column instruments and methods. We provide high-purity reagents, columns, mobile phases, and Post-column instruments for all of our supported applications, including Glyphosate and Carbamates analysis according to EPA methods 547, 531.1 and 531.2. Pickering Laboratories offers a complete solution for Amino Acid Analysis according to European Pharmacopoeia 8.0 now, in addition to numerous other supported Amino Acid applications. Other supported methods include Aflatoxins, Paralytic Shellfish, Formaldehyde, B Vitamins, Sugars and Polyether Antibiotics. Pickering Laboratories is also the Exclusive North American Distributor for LC Tech products. LC Tech manufactures automated sample cleanup systems and consumables for GPC, SPE, IAC, and evaporation methods to support the Food, Agricultural, Environmental, Herbal Products and Clinical markets.
Additionally, as Pickering Test Solutions, we support consumer products manufacturers and testing laboratories. We began by designing the most accurate mimic to true human eccrine perspiration. Ours is also the only formula on the market that allows for standardization across all industries. From there, we launched ourselves into the product testing market. We now offer a wide range of artificial perspirations, salivas, and urines. All of our products testing formulas are made to official testing specifications from ANSI, NIST and other official standards organizations. Our customers use our solutions worldwide for both product testing and research applications. At Pickering Laboratories, our manufacturing processes enable excellent batch reproducibility and precise matching of official formulations. Custom formulations are routinely produced with the same guarantee of precision and reproducibility.
2019
Investing Member
Aug 2019
Portfolia is the most powerful community of women and men investing in the companies we want in the world.
Our collective investments are changing health, active aging & longevity, sustainability, education, and the overall venture capital landscape while also backing diversity.
Our currently open funds are Femtech III, focused on enhancing the wellness of all women, and advancing innovation in womens health; and Active Aging & Longevity II, focused on significant opportunities and challenges in aging well, as well as those focused on new strides and technologies in the field of longevity.
We drive change while creating wealth.
If youd like to join us, email investorrelations@portfolia.com, and our Investor Relations Team will contact you.
Show all 6 entries ↓
Investment activity
2017–2025 · 5 investments
Recent (last 2 years)Earlier
